Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02484053
Title Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Baylor College of Medicine
Indications

cancer

hematologic cancer

Therapies

Rituximab

Age Groups: child
Covered Countries USA


No variant requirements are available.